Neostem gets patent boost for heart drug

|By:, SA News Editor

Neostem (NBS) has received a notice of allowance for what is the sixth granted or allowed U.S. patent for the company's AMR-001 drug, which is designed to preserve heart function after a severe heart attack.

In addition, the EU intends to grant two patents for AMR-001; these would be Neostem's first patents in the region.

AMR-001's total worldwide IP coverage is now 16 granted and allowed patents. (PR)